Treatment strategies for autoimmune encephalitis

Retrospective observations indicate that early aggressive treatment is associated with better functional outcomes and fewer relapses. Immune response to first-line immunotherapeutic agents (corticosteroids, intravenous immunoglobulin, plasma exchange, and immunoadsorption) is fair, but approximately half or more of patients are administered second-line immunotherapy (rituximab and cyclophosphamide). A small but significant proportion of patients are refractory to all first- and second-line therapies and require further treatment. Although several investigations have shown promising alternatives, the low absolute number of patients involved necessitates more evidence to establish further treatment strategies. In this review, the agents used for first- and second-line immunotherapy are discussed and recent attempts at finding new treatment options are introduced.

(click on image)

Receive a Free Subscribtion

Brain&Life contains a wide array of helpful articles for Families, Patients and Caregivers. You can also keep abreast of the latest news in Neurology.

____________

Neurología accesible en español Brain & Life en español es la primera publicación dirigida a hispanohablantes con guías e información accesible sobre el cerebro y el sistema nervioso.